Erschienen in:
01.04.2018 | Images that Teach
Cardiac sarcoidosis after glucocorticoid therapy evaluated by 18F-fluorodeoxyglucose PET/MRI
verfasst von:
Takatoyo Kiko, MD, Atsuro Masuda, MD, PhD, Ayaka Nemoto, BSc, Hideyuki Tominaga, BSc, PhD, Noboru Oriuchi, MD, PhD, Akiomi Yoshihisa, MD, PhD, Yasuchika Takeishi, MD, PhD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 2/2018
Einloggen, um Zugang zu erhalten
Excerpt
Hybrid PET/MRI is used for evaluation of several cardiac diseases.
1 18F-fluorodeoxyglucose (FDG) PET has a high sensitivity for the diagnosis of cardiac sarcoidosis. Cardiac sarcoidosis is a systemic disease that forms non-caseating granulomas on various organs, including the heart. Glucocorticoid therapy suppresses the progression of inflammation in cardiac sarcoidosis. This case is of interest because PET/MRI reveals the beneficial effects of glucocorticoid on inflammation in cardiac sarcoidosis. …